RELATED STUDY
Cannabinoid Receptors and Endocannabinoids: Role in Neuroinflammatory and Neurodegenerative Disorders
Key Findings: The neuro-modulatory actions at CB1 receptors by endocannabinoids, of which anandamide and 2-arachidonoylglycerol are the two most studied representatives, allows them to counteract the neuro-chemical imbalances arising during Alzheimer’s disease, multiple sclerosis, amyotropic lateral sclerosis, Parkinson’s disease, and Huntington’s chorea.
Type of Study: Meta-analysis
Study Result: Positive
Study Location(s): Italy
Year of Pub: 2010
Cannabinoids Studied: Anandamide (AEA), 2-Arachidonoyl Glycerol (2-AG)
Phytocannabinoid Source: Not Applicable
Receptors Studied: CB1
